Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
RENB
Shares outstanding
226,664,950
Price per share
$1.40
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
5
Total reported value
$7
% of total 13F portfolios
0%
Share change
-14,418,363
Value change
-$4,165,731
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
William Anderson Wittekind 8% -24% $6,890,614 18,133,196 0% William Anderson Wittekind 09 Jul 2025

As of 30 Sep 2025, 1 institutional investors reported holding 5 shares of Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB). This represents 0% of the company’s total 226,664,950 outstanding shares.

Institutional Holders of Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 5 $7 -$4,165,731 $1.40 1
2025 Q2 14,426,097 $4,167,462 -$2,600,917 $0.29 41
2025 Q1 22,011,689 $11,955,928 -$181,227 $0.54 60
2024 Q4 22,130,549 $18,494,017 +$6,146,174 $0.84 57
2024 Q3 14,761,228 $7,133,507 +$169,016 $0.48 48
2024 Q2 14,157,443 $24,775,363 +$11,117,231 $1.75 37
2024 Q1 7,245,406 $19,200,126 +$12,268,136 $2.65 40
2023 Q4 2,572,614 $8,156,630 +$3,304,877 $3.17 35
2023 Q3 1,488,192 $6,652,555 +$1,025,340 $4.47 20
2023 Q2 1,849,727 $1,126,647 -$873,336 $0.57 30
2023 Q1 3,303,933 $3,023,286 -$317,455 $0.92 40
2022 Q4 3,630,699 $3,739,039 -$186,936 $1.03 38
2022 Q3 3,770,390 $6,824,610 -$322,962 $1.81 35
2022 Q2 3,939,159 $7,601,528 +$151,242 $1.93 45
2022 Q1 2,604,770 $21,490,710 +$1,349,340 $8.25 41
2021 Q4 2,470,884 $18,009,948 +$6,992,602 $7.29 41
2021 Q3 1,518,637 $10,217,810 -$7,069,450 $6.73 27
2021 Q2 2,668,374 $13,262,947 +$159,629 $4.97 31
2021 Q1 2,712,365 $9,595,115 +$1,002,460 $3.54 39
2020 Q4 2,446,048 $7,222,222 +$133,204 $2.95 40
2020 Q3 2,381,325 $8,536,220 -$333,103 $3.58 37
2020 Q2 2,469,200 $10,397,463 +$797,204 $4.21 32
2020 Q1 2,286,020 $6,854,756 +$338,301 $3.00 31
2019 Q4 2,147,093 $10,777,417 +$4,861,113 $5.02 33
2019 Q3 1,168,546 $6,424,078 -$56,516 $5.50 28
2019 Q2 1,156,990 $5,205,567 +$1,039,625 $4.50 27
2019 Q1 893,362 $6,198,000 +$6,177,000 $6.94 18
2018 Q4 2,941 $21,000 +$21,000 $7.11 2